Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like <b>Affinity Bio</b> Partners And <b>Affinity Bioceuticals</b> September 20, 2017 Oncolytics Biotech Prices Public Offering Of Units May 23, 2017 Alder CEO Is Stepping Down March 20, 2018
